hcpcs_code stringlengths 5 5 | hcpcs_description stringlengths 10 256 | n_providers int64 1 498k | total_services int64 408k 102M | total_medicare_payment int64 11.8k 8.43B | avg_submitted_charge int64 0 9.01k |
|---|---|---|---|---|---|
64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | 7,453 | 583,299 | 110,627,281 | 1,907 |
97597 | Removal of tissue from wound, 20.0 sq cm or less | 5,884 | 579,628 | 33,220,131 | 182 |
81000 | Manual urinalysis test with examination using microscope, non-automated | 3,428 | 579,455 | 2,271,713 | 17 |
84480 | Thyroid hormone, t3 measurement, total | 1,068 | 575,710 | 7,992,487 | 90 |
93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | 12,059 | 574,202 | 2,479,401 | 91 |
72141 | Mri scan of upper spinal canal without contrast | 10,827 | 564,779 | 46,697,414 | 901 |
J0256 | Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg | 6 | 563,396 | 2,155,402 | 11 |
99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 18,351 | 555,578 | 34,109,187 | 275 |
99202 | New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more | 17,327 | 554,116 | 24,468,864 | 166 |
83721 | Ldl cholesterol level | 1,390 | 552,661 | 5,676,081 | 52 |
A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 3,972 | 546,847 | 48,110,814 | 376 |
93925 | Ultrasound of leg arteries or artery grafts | 9,505 | 545,528 | 75,017,529 | 466 |
82977 | Glutamyltransferase (liver enzyme) level | 989 | 545,152 | 3,830,279 | 29 |
96415 | Administration of chemotherapy into vein, each additional hour | 4,837 | 544,416 | 11,582,095 | 129 |
93922 | Ultrasound study of arm and leg arteries | 8,154 | 539,016 | 22,303,529 | 204 |
88311 | Preparation of tissue for examination by removing any calcium present | 6,624 | 538,814 | 5,390,210 | 56 |
G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1,021 | 537,743 | 129,438,547 | 636 |
J9171 | Injection, docetaxel, 1 mg | 161 | 536,335 | 360,702 | 32 |
00812 | Anesthesia for exam of colon using an endoscope | 16,342 | 535,545 | 43,944,484 | 960 |
27447 | Replacement of knee joint, both sides of knee | 12,116 | 533,707 | 642,183,012 | 9,008 |
J0121 | Injection, omadacycline, 1 mg | 8 | 532,710 | 1,578,281 | 11 |
77066 | Diagnostic mammography of both breasts | 8,146 | 532,566 | 31,888,068 | 312 |
J3247 | Injection, secukinumab, intravenous, 1 mg | 42 | 531,540 | 7,286,474 | 41 |
90791 | Psychiatric diagnostic evaluation | 11,400 | 531,319 | 59,754,380 | 305 |
J7331 | Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | 175 | 526,849 | 4,267,066 | 48 |
82247 | Bilirubin level, total | 693 | 524,687 | 2,545,909 | 22 |
82310 | Calcium level, total | 1,390 | 521,932 | 2,622,123 | 21 |
87070 | Bacterial culture, any other source except urine, blood or stool, aerobic | 556 | 520,421 | 4,392,175 | 76 |
95115 | Professional service for single injection of allergen | 1,726 | 519,686 | 3,476,144 | 27 |
86431 | Rheumatoid factor level | 1,267 | 513,177 | 2,848,927 | 44 |
Q5123 | Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | 189 | 512,172 | 16,185,084 | 141 |
87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 13,735 | 510,998 | 17,544,777 | 98 |
31575 | Diagnostic exam of voice box using a flexible endoscope | 8,057 | 510,976 | 44,167,576 | 362 |
J3489 | Injection, zoledronic acid, 1 mg | 3,154 | 509,798 | 2,396,406 | 182 |
77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 3,320 | 508,830 | 92,171,117 | 523 |
76942 | Ultrasonic guidance for needle placement | 12,714 | 508,079 | 17,928,568 | 327 |
74183 | Mri scan of abdomen before and after contrast | 7,593 | 507,291 | 67,933,461 | 1,246 |
11719 | Trimming of fingernails or toenails | 2,224 | 505,782 | 3,829,619 | 37 |
86160 | Measurement of complement (immune system proteins), antigen, | 703 | 504,303 | 5,915,605 | 87 |
84154 | Psa (prostate specific antigen) measurement, free | 1,049 | 504,210 | 9,074,108 | 87 |
82040 | Albumin (protein) level | 1,043 | 504,167 | 2,408,292 | 16 |
17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 2,845 | 502,318 | 159,864,358 | 918 |
72131 | Ct scan of lower spine without contrast | 12,819 | 501,287 | 20,191,228 | 361 |
J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | 52 | 500,244 | 18,904,500 | 123 |
84479 | Thyroid hormone evaluation | 623 | 498,140 | 3,156,309 | 41 |
97130 | Therapy procedure for a range of mental processes, each additional 15 minutes | 601 | 496,028 | 8,309,836 | 46 |
J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 3,290 | 495,106 | 68,531,588 | 1,044 |
96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 3,065 | 494,967 | 7,575,850 | 89 |
86141 | Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | 877 | 493,675 | 6,254,843 | 70 |
83861 | Microfluid analysis of tears | 1,715 | 491,299 | 10,790,560 | 46 |
93308 | Ultrasound of heart, follow-up | 12,148 | 490,430 | 11,062,216 | 168 |
G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1,428 | 489,866 | 94,765,334 | 509 |
83520 | Measurement of substance using immunoassay technique | 358 | 489,577 | 8,258,955 | 136 |
86803 | Hepatitis c antibody measurement | 951 | 486,148 | 6,775,012 | 117 |
J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 175 | 486,020 | 191,152 | 6 |
J3490 | Unclassified drugs | 2,477 | 485,201 | 67,129,159 | 443 |
73221 | Mri scan of arm joint without contrast | 7,815 | 484,373 | 46,193,376 | 921 |
87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 767 | 484,183 | 16,634,416 | 66 |
76937 | Ultrasonic guidance for blood vessel access | 12,208 | 477,828 | 6,514,199 | 101 |
87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 17,090 | 475,768 | 7,631,450 | 45 |
85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | 2,275 | 473,883 | 1,972,983 | 19 |
90792 | Psychiatric diagnostic evaluation with medical services | 8,503 | 473,012 | 58,632,092 | 406 |
86376 | Microsomal antibodies (autoantibody) measurement | 749 | 465,966 | 6,635,021 | 98 |
77002 | Fluoroscopic guidance for needle placement | 6,944 | 463,707 | 32,478,497 | 292 |
99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | 3,859 | 462,283 | 14,336,877 | 101 |
70486 | Ct scan of face without contrast | 13,292 | 457,630 | 21,163,289 | 378 |
99496 | Transitional care management services for problem of high complexity | 16,135 | 456,301 | 90,283,134 | 491 |
G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1,718 | 455,037 | 69,397,158 | 416 |
72040 | X-ray of upper spine, 2-3 views | 12,440 | 454,448 | 7,875,849 | 97 |
99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 1,927 | 453,609 | 21,186,853 | 141 |
92201 | Extended exam of the back part of the eye with retinal drawing | 2,484 | 452,704 | 8,646,876 | 87 |
J0175 | Injection, donanemab-azbt, 2 mg | 24 | 449,525 | 1,441,758 | 10 |
90935 | Hemodialysis procedure with physician evaluation | 5,598 | 448,759 | 24,396,005 | 250 |
J7050 | Infusion, normal saline solution, 250 cc | 1,812 | 446,210 | 227,215 | 16 |
82378 | Carcinoembryonic antigen (cea) protein level | 1,542 | 444,322 | 8,236,615 | 98 |
68761 | Closure of tear duct opening using plug | 3,618 | 444,095 | 46,192,271 | 349 |
87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 12,291 | 443,757 | 29,768,410 | 141 |
74178 | Ct scan of abdomen and pelvis before and after contrast | 11,347 | 442,968 | 59,787,637 | 929 |
84520 | Urea nitrogen level to assess kidney function, quantitative | 1,350 | 439,486 | 1,690,493 | 17 |
93356 | Heart muscle strain imaging | 5,392 | 438,564 | 8,014,395 | 127 |
G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 1,943 | 435,933 | 34,843,870 | 165 |
97032 | Application of electrical stimulation with therapist present, each 15 minutes | 1,308 | 431,028 | 3,826,523 | 40 |
J1556 | Injection, immune globulin (bivigam), 500 mg | 30 | 429,595 | 24,907,173 | 181 |
J9045 | Injection, carboplatin, 50 mg | 1,388 | 429,420 | 1,202,512 | 129 |
J1171 | Injection, hydromorphone, 0.1 mg | 13 | 423,427 | 27,425 | 1 |
92285 | Photography of content of eyes | 4,075 | 423,388 | 6,745,254 | 71 |
82533 | Cortisol (hormone) measurement, total | 950 | 422,881 | 6,742,073 | 82 |
71271 | Low dose ct scan of chest for lung cancer screening | 8,706 | 422,719 | 30,775,969 | 350 |
99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | 1,218 | 422,066 | 16,598,989 | 109 |
11043 | Removal of muscle and/or tissue, 20.0 sq cm or less | 2,164 | 422,018 | 64,619,972 | 516 |
11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | 2,115 | 420,819 | 9,624,690 | 96 |
J0461 | Injection, atropine sulfate, 0.01 mg | 264 | 419,880 | 27,154 | 1 |
84075 | Phosphatase (enzyme) level, alkaline | 707 | 419,811 | 2,090,209 | 16 |
97164 | Re-evaluation for physical therapy, typically 20 minutes | 8,672 | 419,682 | 22,118,812 | 121 |
99441 | Telephone medical discussion with physician, 5-10 minutes | 9,208 | 415,036 | 15,340,821 | 113 |
99495 | Transitional care management services for problem of at least moderate complexity | 18,207 | 414,897 | 58,418,858 | 403 |
82670 | Measurement of total estradiol (hormone) | 973 | 414,565 | 11,324,195 | 162 |
J0873 | Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg | 7 | 411,700 | 11,786 | 1 |
G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 15,851 | 410,373 | 61,985,969 | 357 |
83516 | Analysis of substance using immunoassay technique, multiple step method | 987 | 407,675 | 4,597,591 | 90 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.